{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T18:27:20Z","timestamp":1788805640077,"version":"build-2803163510"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T00:00:00Z","timestamp":1591574400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T00:00:00Z","timestamp":1591574400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"President Fund of Nanfang Hospital","award":["No.2019B007"],"award-info":[{"award-number":["No.2019B007"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s10072-020-04466-7","type":"journal-article","created":{"date-parts":[[2020,6,8]],"date-time":"2020-06-08T12:05:40Z","timestamp":1591617940000},"page":"3691-3696","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Glutamic acid decarboxylase antibodies in neurocritical patients: a culprit or a bystander?"],"prefix":"10.1007","volume":"41","author":[{"given":"Dongmei","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaibin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenzhou","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongfang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanghui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongming","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4941-4071","authenticated-orcid":false,"given":"Shengnan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,6,8]]},"reference":[{"key":"4466_CR1","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jaut.2019.04.007","volume":"101","author":"JF Baizabal-Carvallo","year":"2019","unstructured":"Baizabal-Carvallo JF (2019) The neurological syndromes associated with glutamic acid decarboxylase antibodies. J Autoimmun 101:35\u201347","journal-title":"J Autoimmun"},{"issue":"3","key":"4466_CR2","doi-asserted-by":"publisher","first-page":"215","DOI":"10.17712\/nsj.2016.3.20150596","volume":"21","author":"H Tohid","year":"2016","unstructured":"Tohid H (2016) Anti-glutamic acid decarboxylase antibody positive neurological syndromes. Neurosciences (Riyadh) 21(3):215\u2013222","journal-title":"Neurosciences (Riyadh)"},{"issue":"9","key":"4466_CR3","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.4065\/81.9.1207","volume":"81","author":"SJ Pittock","year":"2006","unstructured":"Pittock SJ, Yoshikawa H, Ahlskog JE, Tisch SH, Benarroch EE, Kryzer TJ, Lennon VA (2006) Glutamic acid decarboxylase autoimmunity with brainstem, extrapyramidal, and spinal cord dysfunction. Mayo Clin Proc 81(9):1207\u20131214","journal-title":"Mayo Clin Proc"},{"issue":"Pt 10","key":"4466_CR4","doi-asserted-by":"publisher","first-page":"2553","DOI":"10.1093\/brain\/awn183","volume":"131","author":"A Saiz","year":"2008","unstructured":"Saiz A, Blanco Y, Sabater L, Gonzalez F, Bataller L, Casamitjana R, Ramio-Torrenta L, Graus F (2008) Spectrum of neurological syndromes associated with glutamic acid decarboxylase antibodies: diagnostic clues for this association. Brain J Neurol 131(Pt 10):2553\u20132563","journal-title":"Brain J Neurol"},{"issue":"6","key":"4466_CR5","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1007\/s10072-019-3701-6","volume":"40","author":"SM Villa","year":"2019","unstructured":"Villa SM, Rufa A, Malandrini A, Cerase A, Rosini F, Arrigucci U, Federico A (2019) Cerebellar ataxia associated with anti-glutamic acid decarboxylase antibodies: a case report. Neurol Sci 40(6):1303\u20131306","journal-title":"Neurol Sci"},{"key":"4466_CR6","doi-asserted-by":"crossref","unstructured":"Zummo L, Coco DL, Lopez G, Palma D, Daniele O (2019) Refractory status epilepticus behind autoimmune encephalitis, Neurol Sci","DOI":"10.1007\/s10072-019-04164-z"},{"issue":"8","key":"4466_CR7","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1001\/jamaneurol.2015.0749","volume":"72","author":"H Arino","year":"2015","unstructured":"Arino H, Hoftberger R, Gresa-Arribas N, Martinez-Hernandez E, Armangue T, Kruer MC, Arpa J, Domingo J, Rojc B, Bataller L, Saiz A, Dalmau J, Graus F (2015) Paraneoplastic neurological syndromes and glutamic acid decarboxylase antibodies. JAMA Neurol 72(8):874\u2013881","journal-title":"JAMA Neurol"},{"issue":"1","key":"4466_CR8","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/S1474-4422(09)70324-2","volume":"9","author":"E Lancaster","year":"2010","unstructured":"Lancaster E, Lai M, Peng X, Hughes E, Constantinescu R, Raizer J, Friedman D, Skeen MB, Grisold W, Kimura A, Ohta K, Iizuka T, Guzman M, Graus F, Moss SJ, Balice-Gordon R, Dalmau J (2010) Antibodies to the GABA(B) receptor in limbic encephalitis with seizures: case series and characterisation of the antigen. Lancet Neurol 9(1):67\u201376","journal-title":"Lancet Neurol"},{"issue":"1","key":"4466_CR9","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1046\/j.1526-0968.1999.00104.x","volume":"3","author":"JH Yeh","year":"1999","unstructured":"Yeh JH, Chen WH, Chen JR, Chiu HC (1999) Miller Fisher syndrome with central involvement: successful treatment with plasmapheresis. Ther Apher 3(1):69\u201371","journal-title":"Ther Apher"},{"issue":"11","key":"4466_CR10","doi-asserted-by":"publisher","first-page":"2399","DOI":"10.1016\/j.clineuro.2013.07.043","volume":"115","author":"H Zhang","year":"2013","unstructured":"Zhang H (2013) Miller Fisher syndrome with positivity of anti-GAD antibodies. Clin Neurol Neurosurg 115(11):2399","journal-title":"Clin Neurol Neurosurg"},{"issue":"2","key":"4466_CR11","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1002\/ana.24881","volume":"81","author":"EP Flanagan","year":"2017","unstructured":"Flanagan EP, Hinson SR, Lennon VA, Fang B, Aksamit AJ, Morris PP, Basal E, Honorat JA, Alfugham NB, Linnoila JJ, Weinshenker BG, Pittock SJ, McKeon A (2017) Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy: Analysis of 102 patients. Ann Neurol 81(2):298\u2013309","journal-title":"Ann Neurol"},{"issue":"9","key":"4466_CR12","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1001\/jamaneurol.2013.3499","volume":"70","author":"T Chang","year":"2013","unstructured":"Chang T, Alexopoulos H, McMenamin M, Carvajal-Gonzalez A, Alexander SK, Deacon R, Erdelyi F, Szabo G, Lang B, Blaes F, Brown P, Vincent A (2013) Neuronal surface and glutamic acid decarboxylase autoantibodies in Nonparaneoplastic stiff person syndrome. JAMA Neurol 70(9):1140\u20131149","journal-title":"JAMA Neurol"},{"issue":"26","key":"4466_CR13","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1056\/NEJMoa01167","volume":"345","author":"MC Dalakas","year":"2001","unstructured":"Dalakas MC, Fujii M, Li M, Lutfi B, Kyhos J, McElroy B (2001) High-dose intravenous immune globulin for stiff-person syndrome. N Engl J Med 345(26):1870\u20131876","journal-title":"N Engl J Med"},{"issue":"10","key":"4466_CR14","doi-asserted-by":"publisher","first-page":"783","DOI":"10.2169\/internalmedicine.48.1802","volume":"48","author":"K Nanri","year":"2009","unstructured":"Nanri K, Okita M, Takeguchi M, Taguchi T, Ishiko T, Saito H, Otsuka T, Mitoma H, Koizumi K (2009) Intravenous immunoglobulin therapy for autoantibody-positive cerebellar ataxia. Intern Med 48(10):783\u2013790","journal-title":"Intern Med"},{"issue":"6","key":"4466_CR15","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1590\/S0004-282X2011000700030","volume":"69","author":"JL Pedroso","year":"2011","unstructured":"Pedroso JL, Braga-Neto P, Dutra LA, Barsottini OG (2011) Cerebellar ataxia associated to anti-glutamic acid decarboxylase autoantibody (anti-GAD): partial improvement with intravenous immunoglobulin therapy. Arq Neuropsiquiatr 69(6):993","journal-title":"Arq Neuropsiquiatr"},{"issue":"3","key":"4466_CR16","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1007\/s12311-013-0534-3","volume":"13","author":"V Planche","year":"2014","unstructured":"Planche V, Marques A, Ulla M, Ruivard M, Durif F (2014) Intravenous immunoglobulin and rituximab for cerebellar ataxia with glutamic acid decarboxylase autoantibodies. Cerebellum 13(3):318\u2013322","journal-title":"Cerebellum"},{"key":"4466_CR17","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.seizure.2015.05.017","volume":"30","author":"MP Malter","year":"2015","unstructured":"Malter MP, Frisch C, Zeitler H, Surges R, Urbach H, Helmstaedter C, Elger CE, Bien CG (2015) Treatment of immune-mediated temporal lobe epilepsy with GAD antibodies. Seizure 30:57\u201363","journal-title":"Seizure"},{"key":"4466_CR18","doi-asserted-by":"publisher","first-page":"579","DOI":"10.3389\/fneur.2018.00579","volume":"9","author":"KM Makela","year":"2018","unstructured":"Makela KM, Hietaharju A, Brander A, Peltola J (2018) Clinical management of epilepsy with glutamic acid decarboxylase antibody positivity: the interplay between immunotherapy and anti-epileptic drugs. Front Neurol 9:579","journal-title":"Front Neurol"},{"issue":"1-2","key":"4466_CR19","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.jns.2009.09.004","volume":"287","author":"F Blanc","year":"2009","unstructured":"Blanc F, Ruppert E, Kleitz C, Valenti MP, Cretin B, Humbel RL, Honnorat J, Namer IJ, Hirsch E, Manning L, de Seze J (2009) Acute limbic encephalitis and glutamic acid decarboxylase antibodies: a reality? J Neurol Sci 287(1-2):69\u201371","journal-title":"J Neurol Sci"},{"key":"4466_CR20","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/1750-1172-8-82","volume":"8","author":"CS Hampe","year":"2013","unstructured":"Hampe CS, Petrosini L, De Bartolo P, Caporali P, Cutuli D, Laricchiuta D, Foti F, Radtke JR, Vidova V, Honnorat J, Manto M (2013) Monoclonal antibodies to 65kDa glutamate decarboxylase induce epitope specific effects on motor and cognitive functions in rats. Orphanet J Rare Dis 8:82","journal-title":"Orphanet J Rare Dis"},{"issue":"6","key":"4466_CR21","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1002\/ana.21123","volume":"61","author":"MU Manto","year":"2007","unstructured":"Manto MU, Laute MA, Aguera M, Rogemond V, Pandolfo M, Honnorat J (2007) Effects of anti-glutamic acid decarboxylase antibodies associated with neurological diseases. Ann Neurol 61(6):544\u2013551","journal-title":"Ann Neurol"},{"key":"4466_CR22","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.expneurol.2012.10.013","volume":"239","author":"N Hansen","year":"2013","unstructured":"Hansen N, Grunewald B, Weishaupt A, Colaco MN, Toyka KV, Sommer C, Geis C (2013) Human Stiff person syndrome IgG-containing high-titer anti-GAD65 autoantibodies induce motor dysfunction in rats. Exp Neurol 239:202\u2013209","journal-title":"Exp Neurol"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-020-04466-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-020-04466-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-020-04466-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T06:11:08Z","timestamp":1744179068000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-020-04466-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,8]]},"references-count":22,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["4466"],"URL":"https:\/\/doi.org\/10.1007\/s10072-020-04466-7","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,8]]},"assertion":[{"value":"22 February 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 May 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the local ethics committee of Nanfang Hospital, Southern Medical University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Informed consent was waived by the review board because this study was an observational and retrospective analysis and all data were fully de-identified.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}